세계의 동물용 광견병 백신 시장 규모 조사 및 예측 : 용도별 및 지역별 분석(2023-2030년)

Global Rabies Veterinary Vaccines Market is valued approximately at USD 584.8 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.10% over the forecast period 2023-2030. The rabies vaccine is an effective way to prevent rabies, which is usually caused by being bitten by a dog or bat. There are many safe and effective rabies vaccines available that can be administered before or after exposure to the virus. The rabies vaccines market growth is driven by factors such as the increase in animal rabies vaccination coverage in developing countries, a greater awareness of zoonotic diseases and growing government initiatives to eradicate animal rabies.

The pet ownership rate is increasing in developed countries, which is driving the market growth. According to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA), about 90.5 million families, or 70% of US households, own a pet. One of the major factors driving market growth over the forecast period is the increasing number of rabies cases worldwide. As of May 2021, dogs are responsible for up to 99% of all human rabies transmissions, making them the leading cause of human rabies mortality worldwide, according to the World Health Organization (WHO). Each year, over 29.0 million people globally seek vaccine bites, and 40.0% of those infected with suspected rabies are infants under 15 years of age, according to the same source. The animal vaccines market is projected to experience steady growth, due to the rising number of cattle and poultry in developing nations. Rabies is a viral disease that can be prevented, but if not prevented or treated in time, it can affect the central nervous system of animals, leading to brain inflammation and death. According to a National Foundation for Infectious Diseases article, the U.S. reports nearly 5,000 rabies cases in animals every year, with over 90% of cases occurring in wildlife, while domestic animals like dogs and cats account for approximately 10% of animal rabies incidents. Moreover, the animal vaccines market's growth is fueled by an increase in investment for research and development of vaccines that inhibit the growth of antibiotic-resistant organisms. This rise in demand for animal vaccines has led to the emergence of many new vaccines. Technologically advanced service providers are expected to boost the market, but the high storage cost of the vaccines and lack of awareness about animal health are stifling market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Rabies Veterinary Vaccines Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. In 2022, North America dominated the market due to a high pet population and significant veterinary healthcare spending. Established veterinary pharmaceutical companies and government organizations are working to implement mass vaccination programs and wildlife rabies bait-vaccine campaigns to combat rabies. Pet owners are also becoming more aware of preventing deadly infections. Asia Pacific is expected to be the fastest-growing region over the forecast period due to a large stray dog population. The region is implementing multiple strategies to eradicate rabies by 2030, including mass dog vaccination programs in collaboration with key players and government organizations. For example, in April 2022, as part of the rabies control initiative, the Global Alliance for Rabies Control (GARC) and Boehringer Ingelheim organized a mass rabies vaccination program in the Philippines, Indonesia, Vietnam, and Malaysia, vaccinating 12,000 animals.

Major market player included in this report are:

• Sanofi SA
• Merck & Co., Inc. (MSD Animal Health)
• Indian Immunologicals Ltd.
• Boehringer Ingelheim International GmbH (Animal Health)
• Zoetis Inc.
• Virbac
• BroadChem Philippines Biopharma Corporation
• Elanco Animal Health Incorporated
• Ceva Sante Animale
• BiogenesisBago

Recent Developments in the Market:

• In June 2022, Ceva Sante Animale acquired Artemis Technologies, Inc., a Canadian company that produces oral rabies vaccines. This acquisition allowed the company to broaden their range of veterinary vaccine by adding ONRAB, a recombinant oral vaccine that has shown promising results in trials conducted on wild skunks and raccoons in the U.S.

Global Rabies Veterinary Vaccines Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Application, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:

• Companion Animals
• Livestock Animals
• Wildlife Animals

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1. Rabies Veterinary Vaccines Market, by Region, 2020-2030 (USD Million)
  • 1.2.2. Rabies Veterinary Vaccines Market, by Application, 2020-2030 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Rabies Veterinary Vaccines Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Rabies Veterinary Vaccines Market Dynamics

• 3.1. Rabies Veterinary Vaccines Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing awareness regarding zoonotic diseases
    • 3.1.1.2. Growing pet ownership rates
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Storage Cost of Rabies Veterinary Vaccines
    • 3.1.2.2. Lack of animal healthcare awareness
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing technological Advancements and services
    • 3.1.3.2. Growing government initiatives to eradicate animal rabies

Chapter 4. Global Rabies Veterinary Vaccines Market: Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economic
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Rabies Veterinary Vaccines Market, by Application

• 5.1. Market Snapshot
• 5.2. Global Rabies Veterinary Vaccines Market by Application, Performance - Potential Analysis
• 5.3. Global Rabies Veterinary Vaccines Market Estimates & Forecasts by Application 2020-2030 (USD Million)
• 5.4. Rabies Veterinary Vaccines Market, Sub Segment Analysis
  • 5.4.1. Companion Animals
  • 5.4.2. Livestock Animals
  • 5.4.3. Wildlife Animals

Chapter 6. Global Rabies Veterinary Vaccines Market, Regional Analysis

• 6.1. Top Leading Countries
• 6.2. Top Emerging Countries
• 6.3. Rabies Veterinary Vaccines Market, Regional Market Snapshot
• 6.4. North America Rabies Veterinary Vaccines Market
  • 6.4.1. U.S. Rabies Veterinary Vaccines Market
    • 6.4.1.1. Application breakdown estimates & forecasts, 2020-2030
  • 6.4.2. Canada Rabies Veterinary Vaccines Market
• 6.5. Europe Rabies Veterinary Vaccines Market Snapshot
  • 6.5.1. U.K. Rabies Veterinary Vaccines Market
  • 6.5.2. Germany Rabies Veterinary Vaccines Market
  • 6.5.3. France Rabies Veterinary Vaccines Market
  • 6.5.4. Spain Rabies Veterinary Vaccines Market
  • 6.5.5. Italy Rabies Veterinary Vaccines Market
  • 6.5.6. Rest of Europe Rabies Veterinary Vaccines Market
• 6.6. Asia-Pacific Rabies Veterinary Vaccines Market Snapshot
  • 6.6.1. China Rabies Veterinary Vaccines Market
  • 6.6.2. India Rabies Veterinary Vaccines Market
  • 6.6.3. Japan Rabies Veterinary Vaccines Market
  • 6.6.4. Australia Rabies Veterinary Vaccines Market
  • 6.6.5. South Korea Rabies Veterinary Vaccines Market
  • 6.6.6. Rest of Asia Pacific Rabies Veterinary Vaccines Market
• 6.7. Latin America Rabies Veterinary Vaccines Market Snapshot
  • 6.7.1. Brazil Rabies Veterinary Vaccines Market
  • 6.7.2. Mexico Rabies Veterinary Vaccines Market
• 6.8. Middle East & Africa Rabies Veterinary Vaccines Market
  • 6.8.1. Saudi Arabia Rabies Veterinary Vaccines Market
  • 6.8.2. South Africa Rabies Veterinary Vaccines Market
  • 6.8.3. Rest of Middle East & Africa Rabies Veterinary Vaccines Market

Chapter 7. Competitive Intelligence

• 7.1. Key Company SWOT Analysis
  • 7.1.1. Company 1
  • 7.1.2. Company 2
  • 7.1.3. Company 3
• 7.2. Top Market Strategies
• 7.3. Company Profiles
  • 7.3.1. Sanofi SA
    • 7.3.1.1. Key Information
    • 7.3.1.2. Overview
    • 7.3.1.3. Financial (Subject to Data Availability)
    • 7.3.1.4. Product Summary
    • 7.3.1.5. Recent Developments
  • 7.3.2. Merck & Co., Inc. (MSD Animal Health)
  • 7.3.3. Indian Immunologicals Ltd.
  • 7.3.4. Boehringer Ingelheim International GmbH (Animal Health)
  • 7.3.5. Zoetis Inc.
  • 7.3.6. Virbac
  • 7.3.7. BroadChem Philippines Biopharma Corporation
  • 7.3.8. Elanco Animal Health Incorporated
  • 7.3.9. Ceva Sante Animale
  • 7.3.10. BiogenesisBago

Chapter 8. Research Process

• 8.1. Research Process
  • 8.1.1. Data Mining
  • 8.1.2. Analysis
  • 8.1.3. Market Estimation
  • 8.1.4. Validation
  • 8.1.5. Publishing
• 8.2. Research Attributes
• 8.3. Research Assumption